Association of homocysteine and methylene tetrahydrofolate reductase (MTHFR C677T) gene polymorphism with coronary artery disease (CAD) in the population of North India

Genetics and Molecular Biology

Volumn 33, Issue 2, 2010, Pages 224-228

  Tripathi, Rajneesh ^a   Tewari, Satyendra ^a   Singh, Prabhat Kumar ^a   Agarwal, Sarita ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Angiography; CAD; Homocysteine; MTHFR polymorphism

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE SEVERITY; FAMILY HISTORY; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOSITY; HUMAN; HYPERTENSION; INDIA; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 77954371691     PISSN: 14154757     EISSN: 16784685     Source Type: Journal    
DOI: 10.1590/S1415-47572010005000026     Document Type: Article

References (29)

1. Alam MA, Husain SA, Narang R, Chauhan SS, Kabra M and Vasisht S (2008) Association of polymorphism in the thermolabile 5, 10-methylene tetrahydrofolate reductase gene and hyperhomocysteinemia with coronary artery disease. Mol Cell Biochem 310:111-117.
2. Allain CC, Poon LS, Chan CSG, Richmond W and Fu PC (1974) Enzymatic determination of total serum cholesterol. Clin Chem 20:470-478.
3. Anderson JL, King GJ, Thomson MJ, Todd M, Bair TL, Muhlestein JB and Carlquist JF (1997) A mutation in the methylenetetrahydrofolate reductase gene is not associated with increased risk for coronary artery disease or myocardial infarction. J Am Coll Cardiol 30:1206-1211.
4. Andreassi MG, Botto N, Cocci F, Battaglia D, Antonioli E, Masetti S, Manfredi S, Colombo MG, Biagini A and Clerico A (2003) Methylenetetrahydrofolate reductase gene C677T polymorphism, homocysteine, vitamin B12, and DNA damage in coronary artery disease. Hum Genet 112:171-177.
5. Arruda VR, Siqueira LH, Gonçalves MS, von Zuben PM, Soares MC, Menezes R, Annichino-Bizzacchi JM and Costa FF (1998) Prevalence of the mutation C677 > T in the methylene tetrahydrofolate reductase gene among distinct ethnic groups in Brazil. Am J Med Genet 78:332-335.
6. Bova I, Chapman J, Sylantiev C, Korczyn AD and Bornstein NM (1999) The A677V methylenetetrahydrofolate reductase gene polymorphism and carotid atherosclerosis. Stroke 30:2180-2182.
7. Doevendans PA, Jukema W, Spiering W, Defesche JC and Kastelein JJ (2001) Molecular genetics and gene expression in atherosclerosis. Int J Cardiol 80:161-172.
8. Evans RW, Shaten BJ, Hempel JD, Cutler JA and Kuller LH (1997) Homocysteine and risk of cardiovascular disease in multiple risk factor interventional trial. Arterioscler Thromb Vasc Biol 17:1947-1953.
9. Fauci AS, Braundwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL and Loscalzo J (2008) The pathogenesis of atherosclerosis. In: Harrison's Principle of Internal Medicine. 17th edition. Mc GrawHill, New York, pp 1425-1433.
10. Fossati P and Prencipe L (1982) Serum triglyceride determination calorimetrically with an enzyme that provides hydrogen peroxide. Clin Chem 28:2077-2082.
11. Frantzen F, Faaren AL, Alfheim I and Nordhei AK (1998) Enzyme conversion immunoassay for determining total homocysteine in plasma or serum. Clin Chem 44:311-316.
12. Friedewald WT, Levy RI and Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502.
13. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP et al. (1995) A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase gene. Nat Genet 10:111-113.
14. Gülec S, Aras O, Akar E, Tutar E, Omürlü K, Avci F, Dinçer I, Akar N and Oral D(2001) Methylenetetrahydrofolate reductase gene polymorphism and risk of premature myocardial infarction. Clin Cardiol 24:281-284.
15. Hankey GJ and Eikelboom JW (1999) Homocysteine and vascular disease. Lancet 354:407-413.
16. Hofmann MA, Lalla E, Lu Y, Gleason MR, Wolf BM, Tanji N, Ferran Jr LJ, Kohl B, Rao V and Kisiel W et al. (2001) Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model. J Clin Invest 107:675-683.
17. Hsu LA, Ko YL, Wang SM, Chang CJ, Hsu TS, Chiang CW and Lee YS (2001) The C677T mutation of the methylenetetrahydrofolate reductase gene is not associated with the risk of coronary artery disease or venous thrombosis among Chinese in Taiwan. Hum Hered 51:41-45.
18. Kerkeni M, Addad F, Chauffert M, Myara A, Gerhardt M, Chevenne D, Trivin F, Farhat MB, Miled A and Maaroufi K (2006) Hyperhomocysteinaemia, methylenetetrahydrofolate reductase polymorphism and risk of coronary artery disease. Ann Clin Biochem 43:200-206.
19. Kluijtmans LA, van den Heuvel LP, Boers GH, Frosst P, Stevens EM, van Oost BA, den Heijer M, Trijbels FJ, Rozen R and Blom HJ (1996) Molecular genetic analysis in mild hyperhomocysteinemia: A common mutation in the methylenetetrahydrofolate gene is as a genetic risk factor for cardiovascular disease. Am J Hum Genet 58:35-41.
20. Lobo A, Naso A, Arheart K, Kruger WD, Abou-Ghazala T, Alsous F, Nahlawi M, Gupta A, Moustapha A and van Lente F et al. (1999) Reduction of homocysteine levels in coronary artery disease by low-dose folic acid combined with vitamins B6 and B12. Am J Cardiol 83:821-825.
21. Lopes-Virella MF, Stone P, Ellis S and Colwell JA (1977) Cholesterol determination in high density lipoprotein separated by three different methods. Clin Chem 23:882-888.
22. Morita H, Taguchi J, Kurihara H, Kitaoka M, Kaneda H, Kurihara Y, Maemura K, Shindo T, Minamino T and Ohno M et al. (1997) Genetic polymorphism of 5, 10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease. Circulation 95:2032-2036.
23. Poncz M, Solowiejczyk D, Harpel B, Mory Y, Schwartz E and Surrey S (1982) Construction of human gene libraries from small amounts of peripheral blood: Analysis of beta-like globin genes. Hemoglobin 6:27-36.
24. Rassoul F, Richter V, Hentschel B, Geisel J, Herrmann W and Kuntze T (2008) Plasma homocysteine levels & 677C-T methylenetetrahydrofolate reductase gene polymorphism in patients with coronary artery disease of different severity. Indian J Med Res 127:154-158.
25. Robinson K, Mayer EL, Miller DP, Green R, van Lente F, Gupta A, Kottke-Marchant K, Savon SR, Selhub J and Nissen SE (1995) Hyperhomocysteinemia and low pyridoxal phosphate: Common and independent reversible risk factors for coronary artery disease. Circulation 92:2825-2830.
26. Tyagi SC (1998) Homocysteine redox receptor and regulation of extracellular matrix components in vascular cells. Am J Physiol 274:C396-405.
27. Van Bockxmeer FM, Mamotte CDS, Vasikaran SD and Taylor RR (1997) Methylenetetrahydrofolate reductase gene and coronary artery disease. Circulation 95:21-23.
28. Wang XL, Duarte N, Cai H, Adachi T, Sim AS, Cranney G and Wilcken DE (1999) Relationship between total plasma homocysteine, polymorphisms of homocysteine metabolism related enzymes, risk factors and coronary artery disease in the Australian hospital-based population. Atherosclerosis 146:133-140.
29. Welch GN, Upchurch Jr G and Loscalzo J (1997) Hyperhomocyst (e)inemia and atherothrombosis. Ann N Y Acad Sci 811:48-58.